Clinical Correlates and Prognostic Value of Mallory-Denk Bodies in Hepatitis C: Analysis of the Halt-C Cohort

被引：0
|
作者：
Rakoski, Mina O.
Brown, Morton B.
Fontana, Robert J.
Bonkovsky, Herbert L.
Lok, Anna S.
Omary, Bishr
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
235
引用
收藏
页码：S780 / S780
页数：1
相关论文
共 32 条
  • [1] Mallory-Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C
    Rakoski, Mina O.
    Brown, Morton B.
    Fontana, Robert J.
    Bonkovsky, Herbert L.
    Brunt, Elizabeth M.
    Goodman, Zachary D.
    Lok, Anna S.
    Omary, M. Bishr
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (10) : 902 - U148
  • [2] Altered regulation of LncRNA analysis of human alcoholic hepatitis with Mallory-Denk Bodies (MDBs) is revealed by RNA sequencing
    Zhong, Bei
    Dong, Jun
    Zhang, Rong
    He, Menghua
    Zeng, Wuyi
    Pan, Jiayi
    He, Jiashan
    Tao, Ailin
    Yang, Rirong
    Fu, Bishi
    French, Samuel W.
    Liu, Hui
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 117
  • [3] Fibrosis Progression in Chronic Hepatitis C: Morphometric Image Analysis in the HALT-C Trial
    Goodman, Zachary D.
    Stoddard, Anne M.
    Bonkovsky, Herbert L.
    Fontana, Robert J.
    Ghany, Marc G.
    Morgan, Timothy R.
    Wright, Elizabeth C.
    Brunt, Elizabeth M.
    Kleiner, David E.
    Shiffmann, Mitchell L.
    Everson, Gregory T.
    Lindsay, Karen L.
    Dienstag, Jules L.
    Morishima, Chihiro
    HEPATOLOGY, 2009, 50 (06) : 1738 - 1749
  • [4] Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT-C cohort
    Lok, ASF
    Ghany, MG
    Goodman, ZD
    Wright, EC
    Everson, GT
    Sterling, RK
    Everhart, JE
    Lindsay, KL
    Bonkovsky, HL
    Di Bisceglie, AM
    Lee, WM
    Morgan, TR
    Dienstag, JL
    Morishima, C
    HEPATOLOGY, 2005, 42 (02) : 282 - 292
  • [5] PREDICTING CLINICAL OUTCOME USING STANDARD LABORATORY TESTS: ANALYSIS OF THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) COHORT
    Ghany, Marc G.
    Lok, Anna S. F.
    Everhart, James E.
    Everson, Gregory T.
    Lee, William M.
    Curto, Teresa M.
    Wright, Elizabeth C.
    Stoddard, Anne M.
    HEPATOLOGY, 2008, 48 (04) : 1105A - 1105A
  • [6] Dietary Cholesterol Intake is Associated with Liver Disease Progression in Hepatitis C Infection: Analysis of the HALT-C trial
    Yu, Lei
    Morishima, Chihiro
    Ioannou, George
    HEPATOLOGY, 2012, 56 : 647A - 648A
  • [7] Host immune responses do not correlate with histologic injury: Baseline analysis of the HALT-C trial in advanced hepatitis C disease.
    Rothman, AL
    Morishima, C
    Ray, R
    Chang, M
    Bonkovsky, HL
    Di Bisceglie, A
    Lee, WM
    Lindsay, KL
    Gretch, DR
    Sullivan, DG
    Polyak, SJ
    Wright, EC
    Koziel, MJ
    HEPATOLOGY, 2003, 38 (04) : 467A - 467A
  • [8] Clinical model to predict cirrhosis in patients in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
    Lok, AS
    Everhart, JE
    Everson, G
    Wright, EC
    Sterling, R
    Ghany, M
    Goodman, Z
    HEPATOLOGY, 2002, 36 (04) : 315A - 315A
  • [9] Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    GASTROENTEROLOGY, 2014, 146 (05) : S966 - S966
  • [10] THE EXTRAHEPATIC SITE OF HEPATITIS C VIRUS: CLINICAL MANIFESTATIONS AND PROGNOSTIC VALUE
    Krel, P. E.
    Tsinzerling, O. D.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (11) : 63 - 68
1234